From enterprise software to drug discovery, artificial intelligence is triggering seismic shifts in corporate R&D strategies. SAP is investing €2 billion annually in AI while planning to cut up to 10,000 jobs. OpenAI is pivoting from its nonprofit roots toward a for-profit model valued at $80 billion. Hardware giants like Intel and AMD are slashing…